Europe Hemorrhoid Treatment Devices Market

Europe Hemorrhoid Treatment Devices Market Size (2024 to 2029)

The hemorrhoid treatment devices market in Europe is estimated to grow at a CAGR of 4.43% from 2023 to 2028 and the regional market size is anticipated to be worth USD 317.9 million by 2028 from USD 255.9 million in 2023.

The increasing incidence of hemorrhoid cases in the European region primarily drives the growth of the hemorrhoid treatment devices market in Europe. In the UK, approximately 80% of the population experiences hemorrhoid-related issues at least once in their lifetime. Hemorrhoids, characterized by swollen veins in the anus and lower rectum, can occur internally or externally. Factors such as chronic constipation, diarrhoea, straining during bowel movements, low fiber intake and changes in metabolism contribute to the development of hemorrhoids. Unhealthy dietary habits, including the consumption of junk food and soft drinks, also contribute to the prevalence of hemorrhoids. To address these conditions, individuals with chronic hemorrhoids seek treatment procedures using specialized hemorrhoid treatment devices, thereby driving the market growth.

The growing geriatric population and the rapid adoption of these devices in hospitals and clinics further fuel the growth rate of the Europe hemorrhoid treatment devices market. The demand for effective treatment solutions is on the rise due to the aging population experiencing hemorrhoid issues. The adoption of minimally invasive surgeries among seniors is contributing to the European market growth. These surgeries offer advantages such as reduced incisions, shorter hospital stays, and faster recovery, leading to their increased acceptance. Consequently, healthcare providers are utilizing hemorrhoid treatment devices to address hemorrhoid-related conditions resulting from the growing number of surgeries.

The continuous advancements in the hemorrhoid treatment devices market propel the European market growth. Manufacturers are investing in research and development to incorporate advanced technologies such as infrared coagulation and bipolar into these devices to enhance their treatment efficacy. There is a growing emphasis on the production of customized hemorrhoid treatment devices to provide patients with painless treatment options. The favorable government support, increased investments in research and development and the approval of new products further support the European market growth.

Lack of awareness among the population about hemorrhoids and available treatment options and social stigma and reluctance to discuss about their symptoms and seek proper medical attention for hemorrhoid and the availability of alternative treatments, such as home remedies or over-the-counter medications primarily hamper the growth of the hemorrhoid treatment devices market in Europe. High costs associated with these devices, stringent regulations and approval processes for medical devices in Europe and inadequate or limited reimbursement coverage by healthcare systems and insurance providers for hemorrhoid treatment devices further inhibit the growth rate of the European market.

This research report on the Europe hemorrhoid treatment devices market has been segmented and sub-segmented into the following categories.

By Device Type

• Band Ligators
• Infrared Coagulators
• Sclerotherapy Injectors
• Bipolar Probes
• Hemorrhoid Laser Probes
• Cryotherapy Devices
• Others

By End-Use

• Clinics and Hospitals
• Ambulatory Surgical Centers
• Others

By Country

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

Geographically, Europe accounted for a prominent share of the global market in 2022 and is estimated to grow at a notable CAGR during the forecast period owing to the growing investments by healthcare organizations, increasing healthcare expenditure, rising number of initiatives from the European governments and awareness campaigns aimed at promoting hemorrhoid treatment. Germany stands out as a key contributor to the European market. The availability of advanced treatment options and an increasing number of regulatory approvals for new devices in Germany drives the German market growth. The growing number of clinical trial activities, strategic partnerships and mergers further propel the German market growth. The UK market is anticipated to account for a noteworthy share of the European market during the forecast period owing to the presence of manufacturing facilities enables cost-effective production of treatment devices.

KEY MARKET PLAYERS

Medtronic plc, Johnson & Johnson Services, Inc., Boston Scientific Corporation, Cook Medical and CONMED Corporation are some of the notable players in the European hemorrhoid treatment devices market.